기업 프로필 · Industrials

Nordson Corporation

NDSN · 미국
거래소
미국
국가 / 지역
USA
상장일
1990년 3월 26일
직원 수
8,200
웹사이트
www.nordson.com
현재가
$297.39
실시간 · 2026년 7월 27일
적정 매수가
≤ $250
안전마진 진입가
베일리 성장 점수
44/100
다소 약함
내재가치 · 3단계 구간 현재가 $297.39 실시간 · 적정 내재가치 구간 내

종합 밸류에이션 구간 · 보수적 $225–$240 / 적정 $285–$315 / 낙관적 $400–$430. $297.39 기준, 적정 내재가치 구간 내.

보고서 발행 시 $287.33(2026년 5월 30일)

시가총액US$164.8억
매출 (TTM)US$29.04억
EBITDAUS$9.11억
순이익률18.19%
ROE17.14%
PER (TTM)31.17
선행 PER23.36
PEG1.8
EPSUS$9.49
배당수익률1.11%
52주 범위US$204.40 – US$307.74
애널리스트 목표주가US$319.13
애널리스트 평가4.2 / 5

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The Industrial Precision Solutions segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems; components and systems for thermoplastic and biopolymer melt stream; fluid components, such as nozzles, pumps, and filters; smart components that measure and control the flow, quantity and location of dispensed fluid; control systems; and product assembly solutions. It also offers automated and manual dispensing products and systems for cold materials, container coating, liquid finishing, and powder coating, as well as ultraviolet equipment. The Medical and Fluid Solutions segment offers precision manual and semi-automated dispensers, plastic molded syringes, cartridges, tips, and fluid connection components; interventional solutions for engineered shafts and interventional delivery systems, medical tubing, balloons, balloon inflators, nitinol devices, cardiovascular cannula, and biomaterial delivery; medical fluid components; and microplegia myocardial protection devices and related consumables. The Advanced Technology Solutions segment provides automated dispensing systems for high-speed, precise application of various attachment, protection, and coating fluids, and related gas plasma treatment systems; destructive and non-destructive testing technologies, such as bond testers and automated optical, acoustic microscopy, and x-ray inspection systems used in the semiconductor and printed circuit board industries; and precision measurement and control technologies. The company markets its products through direct sales force, distributors, and sales representatives. Nordson Corporation was founded in 1909 and is headquartered in Westlake, Ohio.

연혁

Nordson Corporation was founded in 1909 and is headquartered in Westlake, Ohio. The company went public on March 26, 1990 and today employs about 8,200 people. It has grown into a precision fluid-management, precision-dispensing, test-and-inspection and medical-components platform organized into three operating segments: Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions. Revenue rose from $2.362 billion in fiscal 2021 to $2.792 billion in fiscal 2025, and reached $1.41 billion in the first half of fiscal 2026, up about 8.6% year over year. The company has expanded materially through acquisitions, including ARAG in 2023, Atrion in 2024, and CyberOptics, which enlarged the platform while also raising goodwill and debt. Sundaram Nagarajan has served as CEO since 2019, and Nordson holds a record of 62 consecutive years of annual dividend increases.

업계 내 위치

Nordson is a high-margin, multi-niche precision industrial platform spanning dispensing, coating, sealing, polymer processing, quality testing and inspection, and medical catheter, balloon, infusion and fluid-connection components. Its customer base is highly diversified across consumer durables, consumer non-durables, industrial, electronics, medical, agriculture, automotive and construction end markets, with no single customer accounting for more than 10% of revenue in 2025. The company sustains a long-term gross margin of roughly 54%-55%, reflecting value rooted in process know-how, reliability, validation, application engineering and parts/consumables rather than simple manufacturing. Its competitive position rests on process embedding, application engineering, a global direct sales and service network spanning more than 35 countries, brand and reliability, and switching costs that arise when its equipment is validated into customer processes in medical and electronics applications; customer relationships in acquired assets often span 17-22 years. The company holds more than 2,200 active patents and over 1,000 trademarks, operates under the Nordson Business System, and demonstrated pricing ability in 2022 when it raised prices to offset inflation. In its 2025 proxy statement Nordson listed peers including Graco, IDEX, AMETEK, Entegris, MKS and Teleflex, reflecting its profile as a platform straddling industrial, medical and electronics niches.

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.